Genetically engineered nano‐melittin vesicles for multimodal synergetic cancer therapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetically engineered nano‐melittin vesicles for multimodal synergetic cancer therapy
Authors
Keywords
-
Journal
Bioengineering & Translational Medicine
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-01-05
DOI
10.1002/btm2.10482
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetically Engineered Nanohyaluronidase Vesicles: A Smart Sonotheranostic Platform for Enhancing Cargo Penetration of Solid Tumors
- (2022) Shuyu Xu et al. ADVANCED FUNCTIONAL MATERIALS
- Targeted therapies for cancer
- (2022) Zhijun Zhou et al. BMC Medicine
- Tumor-reactive antibodies evolve from non-binding and autoreactive precursors
- (2022) Roei D. Mazor et al. CELL
- Pulsed Laser Excited Photoacoustic Effect for Disease Diagnosis and Therapy
- (2022) Zhixiong Wang et al. CHEMISTRY-A EUROPEAN JOURNAL
- Fluorinated Copolypeptide‐Stabilized Microbubbles with Maleimide‐Decorated Surfaces as Long‐Term Ultrasound Contrast Agents
- (2022) Jie Cen et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Peptide–Drug Conjugates with Different Linkers for Cancer Therapy
- (2021) Mona Alas et al. JOURNAL OF MEDICINAL CHEMISTRY
- Extracellular vesicles in cancer diagnostics and therapeutics
- (2021) Adeeb Shehzad et al. PHARMACOLOGY & THERAPEUTICS
- In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis
- (2021) Seohyun Kim et al. Journal for ImmunoTherapy of Cancer
- Regulated cell death pathways in doxorubicin-induced cardiotoxicity
- (2021) Effimia Christidi et al. Cell Death & Disease
- Multi-disciplinary approach for the management of non-metastatic non-small cell lung cancer in the Middle East and Africa: Expert panel recommendations
- (2021) Erdem Göker et al. LUNG CANCER
- Extracellular vesicles as a next-generation drug delivery platform
- (2021) Inge Katrin Herrmann et al. Nature Nanotechnology
- Engineered Cell Membrane‐Derived Nanoparticles in Immune Modulation
- (2021) Yixiao Yang et al. Advanced Science
- Nanosonosensitizers With Ultrasound-Induced Reactive Oxygen Species Generation for Cancer Sonodynamic Immunotherapy
- (2021) Danling Cheng et al. Frontiers in Bioengineering and Biotechnology
- Top 10 Challenges in Cancer Immunotherapy
- (2020) Priti S. Hegde et al. IMMUNITY
- Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapy
- (2020) David G. Millar et al. NATURE BIOTECHNOLOGY
- Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response
- (2020) Xiang Yu et al. Nature Communications
- Small molecules, big impact: 20 years of targeted therapy in oncology
- (2020) Philippe L Bedard et al. LANCET
- Methotrexate-loaded tumour-cell-derived microvesicles can relieve biliary obstruction in patients with extrahepatic cholangiocarcinoma
- (2020) Yunfeng Gao et al. Nature Biomedical Engineering
- Tumor-infiltrating lymphocytes: Warriors fight against tumors powerfully
- (2020) Baisheng Lin et al. BIOMEDICINE & PHARMACOTHERAPY
- Sonodynamic therapy-derived multimodal synergistic cancer therapy
- (2020) Mimi Xu et al. CANCER LETTERS
- An overview of process development for antibody-drug conjugates produced by chemical conjugation technology
- (2020) Yutaka Matsuda et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Immune modulation of liver sinusoidal endothelial cells by melittin nanoparticles suppresses liver metastasis
- (2019) Xiang Yu et al. Nature Communications
- Vesicular Antibodies: A Bioactive Multifunctional Combination Platform for Targeted Therapeutic Delivery and Cancer Immunotherapy
- (2019) Xue Liu et al. ADVANCED MATERIALS
- Next-Generation Cancer Immunotherapy Targeting Glypican-3
- (2019) Yasuhiro Shimizu et al. Frontiers in Oncology
- Rational combinations of immunotherapy with radiotherapy in ovarian cancer
- (2019) Fernanda G Herrera et al. LANCET ONCOLOGY
- Glypican 3-Targeted Therapy in Hepatocellular Carcinoma
- (2019) Takahiro Nishida et al. Cancers
- MMP14 in Sarcoma: A Regulator of Tumor Microenvironment Communication in Connective Tissues
- (2019) Jordi Gonzalez-Molina et al. Cells
- Cancer and the Immune System: The History and Background of Immunotherapy
- (2019) Maura Abbott et al. Seminars in Oncology Nursing
- Anti-Tumor Effects of Melittin and Its Potential Applications in Clinic
- (2018) Can Lyu et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Chemotherapy medication errors
- (2018) Saul N Weingart et al. LANCET ONCOLOGY
- Shedding light on the cell biology of extracellular vesicles
- (2018) Guillaume van Niel et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Combinatory Cancer Therapeutics with Nanoceria-Capped Mesoporous Silica Nanocarriers through pH-triggered Drug Release and Redox Activity
- (2018) Rajendra K. Singh et al. ACS Applied Materials & Interfaces
- Supramolecular Hydrogel Based on Chlorambucil and Peptide Drug for Cancer Combination Therapy
- (2018) Lijun Yang et al. ACS Applied Materials & Interfaces
- A novel melittin nano-liposome exerted excellent anti-hepatocellular carcinoma efficacy with better biological safety
- (2017) Jie Mao et al. Journal of Hematology & Oncology
- Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
- (2017) Fubo Zhou et al. MEDICINAL RESEARCH REVIEWS
- Antibody-drug conjugates: recent advances in conjugation and linker chemistries
- (2016) Kyoji Tsuchikama et al. Protein & Cell
- Virus-mimetic nanovesicles as a versatile antigen-delivery system
- (2015) Pengfei Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
- (2014) Qiong Wu et al. CANCER LETTERS
- Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma
- (2014) Masafumi Ikeda et al. CANCER SCIENCE
- Melittin: A lytic peptide with anticancer properties
- (2013) Goran Gajski et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Anti-Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer
- (2008) T. Ishiguro et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started